Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AIDS (Acquired Immunodeficiency Syndrome)”

Showing 20 of 0 results

Not applicableStudy completedNCT00703404
What this trial is testing

Response to Standard HIV Treatment in Bamako, Mali

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 76
Not applicableStudy completedNCT00904384
What this trial is testing

Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in HIV+ Patients

Who this might be right for
HIV InfectionsCOPD
Cimera 350
Not applicableStudy completedNCT04077138
What this trial is testing

Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Intervention Development

Who this might be right for
HIV/AIDSGenderBehavior and Behavior Mechanisms
Hektoen Institute for Medical Research 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05631093
What this trial is testing

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 553
Post-approval studies (Phase 4)UnknownNCT04746547
What this trial is testing

Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TB

Who this might be right for
TuberculosisHiv
University of KwaZulu 20
Early research (Phase 1)Study completedNCT00119873
What this trial is testing

Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT01575405
What this trial is testing

Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally

Who this might be right for
HIV Prevention
Ian McGowan 13
Testing effectiveness (Phase 2)Study completedNCT00184951
What this trial is testing

Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients

Who this might be right for
HIV InfectionsHyperlipidemia
Radboud University Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00001031
What this trial is testing

A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 296
Not applicableStudy completedNCT06368453
What this trial is testing

Evaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-Test

Who this might be right for
Human Immunodeficiency Virus I InfectionHuman Immunodeficiency Virus II Infection
bioLytical Laboratories 1,728
Not applicableStudy completedNCT00014053
What this trial is testing

Immune System Activity in Healthy Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT01549119
What this trial is testing

Phase I/IIa Dose-escalation Clinical Study of VAC-3S

Who this might be right for
HIV-1 Infection
InnaVirVax 33
Not applicableStudy completedNCT02516930
What this trial is testing

A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in China

Who this might be right for
Human Immunodeficiency VirusSexually Transmitted Diseases
University of North Carolina, Chapel Hill 1,173
Not applicableStudy completedNCT02921841
What this trial is testing

Digital Star: HIV Prevention for Youth in Mental Health Treatment

Who this might be right for
Human Immunodeficiency VirusMental Health
Rhode Island Hospital 125
Early research (Phase 1)Study completedNCT00213005
What this trial is testing

Safety and Acceptability of Carraguard® in HIV Positive Women and Men

Who this might be right for
HIV Infections
Population Council 60
Not applicableStudy completedNCT04048629
What this trial is testing

Impact of Point-of-care (POC) Viral Load (VL) Testing During Pregnancy in Zimbabwe

Who this might be right for
HIV Infections
Clinton Health Access Initiative Inc. 1,715
Post-approval studies (Phase 4)Ended earlyNCT01591902
What this trial is testing

Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

Who this might be right for
Diabetic RetinopathyHIV
Theratechnologies 129
Not applicableStudy completedNCT02455583
What this trial is testing

An Assessment of an HIV Prevention Intervention (Project AIM) Among Junior Secondary School Students in Eastern Botswana

Who this might be right for
HIV
Centers for Disease Control and Prevention 4,732
Post-approval studies (Phase 4)Study completedNCT01813357
What this trial is testing

Does Rosuvastatin Delay Progression of Atherosclerosis in HIV

Who this might be right for
HIVCardiovascular Disease
Bayside Health 84
Testing effectiveness (Phase 2)Study completedNCT03525730
What this trial is testing

LRAs United as a Novel Anti-HIV Strategy.

Who this might be right for
HIV-1-infection
Erasmus Medical Center 28
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation